Results 51 to 60 of about 8,456 (172)

Graves` orbitopathy: frequency of ocular hypertension and glaucoma

open access: yes, 2009
Purpose To determine the relationship between ocular hypertension and glaucoma in patients with Graves` orbitopathy. Methods A total of 107 patients with a diagnosis of Graves` orbitopathy, followed at the Oculoplasty sector of the University Hospital ...
CRUZ, A. A. V.   +3 more
core   +1 more source

PROTEOMICS OF ORBITAL TISSUE IN THYROID-ASSOCIATED ORBITOPATHY.

open access: yes, 2015
A potentially altered protein expression profile in orbital tissue from patients with thyroid-associated orbitopathy (TAO) is ...
Pfeiffer, N   +10 more
core   +1 more source

Endoscopic orbital decompression for Graves′ orbitopathy

open access: yes, 2013
Aim: To study the efficacy of endonasal endoscopic orbital decompression in cases of Graves′ orbitopathy. Material and Methods: A total of 24 orbits in 12 patients underwent endoscopic orbital decompression for graves orbitopathy in the period between ...
Priti Lal, Alok Thakar, Nikhil Tandon
core   +1 more source

EMERGENCY TREATMENT OF GRAVES ORBITOPATHY

open access: yes, 2011
GRAVES ORBITOPATHY EMERGENCY DEPARTMENT SUDDEN IMPAIRMENT ...
CARINI, Luisa   +8 more
core  

ePosters Virtual

open access: yes
European Journal of Neurology, Volume 33, Issue S1, June 2026.
wiley   +1 more source

Novel treatment modalities for Graves' orbitopathy

open access: yes, 2010
Non-surgical treatments for moderate to severe and active Graves' orbitopathy (systemic glucocorticoids with or without orbital radiotherapy) have limited effects on the underlying autoimmune process causing the disease.
AZZOLINI, CLAUDIO   +9 more
core  

Statin reduces orbitopathy risk in patients with Graves’ disease by modulating apoptosis and autophagy activities

open access: yes, 2016
Statins use has been associated with reduced risk for developing orbitopathy among patients with Graves’ disease. We hypothesize that statin reduces orbitopathy risk mainly by modulating both apoptosis and autophagy activities in patients with Graves ...
Ciaglia Elena   +3 more
core   +1 more source

Clinical characteristics of Graves’ orbitopathy [PDF]

open access: yes, 2014
State Medical and Pharmaceutical University “Nicolae Testemitanu”, Chisinau, Republic of MoldovaIntroduction: Graves’ orbitopathy (GO) constitutes a major clinical and therapeutic challenge. GO is an autoimmune disorder representing the most common and
Iacob, Sergiu
core  

Quality of life in Graves' orbitopathy

open access: yes, 2011
The quality of life of patients with Graves' orbitopathy (GO) may be seriously damaged due to the changes in appearance, working abilities and everyday activities. The reasons for the deterioration in quality of life in GO are proptosis, diplopiae and/or
Ćirić Jasmina
core   +1 more source

Impact of Graves' orbitopathy on quality of life

open access: yes, 2014
Objective. This study was conducted to assess the impact of Graves' orbitopathy on the quality of life in our population by using disease-specific questionnaire (GO-QOL) recommended by the European Group on Graves' Orbitopathy (EUGOGO). Methods.
Bubanja D.   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy